Managing Changes in Life After Deep Brain Stimulation for Parkinson's Disease Trial N/A Completed May 30, 2017
Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999 Trial Early Phase 1 Terminated May 29, 2017
Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD) Trial N/A Completed May 29, 2017
Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers Trial Phase 2 Completed May 22, 2017
A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis Trial Phase 3 Completed May 18, 2017
Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease Trial N/A Completed May 17, 2017
A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis Trial Phase 3 Completed May 16, 2017
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa Trial Phase 3 Completed May 16, 2017
Assessment of Three-dimensional Vision Alteration in Parkinson Disease Trial N/A Completed May 11, 2017
Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators Trial N/A Completed May 7, 2017
Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations Trial N/A Recruiting May 2, 2017
Apomorphine in Parkinson's Disease Patients With Visual Hallucinations Trial Phase 2 Unknown May 2, 2017
Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist Trial N/A Unknown May 2, 2017
Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation Trial N/A Withdrawn April 26, 2017
Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease Trial N/A Completed April 26, 2017